Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Vaxcyte Inc (NASDAQ: PCVX) closed at $37.76 down -45.64% from its previous closing price of $69.46. In other words, the price has decreased by -$45.64 from its previous closing price. On the day, 13.99 million shares were traded. PCVX stock price reached its highest trading level at $37.94 during the session, while it also had its lowest trading level at $30.1201.
Ratios:
For a deeper understanding of Vaxcyte Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.75 and its Current Ratio is at 12.75. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $135.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 8934318080 and an Enterprise Value of 3185940736.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.02, which has changed by -0.41393763 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $58.10. The 50-Day Moving Average of the stock is -52.29%, while the 200-Day Moving Average is calculated to be -57.60%.
Shares Statistics:
For the past three months, PCVX has traded an average of 1.13M shares per day and 2263660 over the past ten days. A total of 128.76M shares are outstanding, with a floating share count of 125.07M. Insiders hold about 2.86% of the company’s shares, while institutions hold 107.92% stake in the company. Shares short for PCVX as of 1741910400 were 12609286 with a Short Ratio of 11.15, compared to 1739491200 on 13334612. Therefore, it implies a Short% of Shares Outstanding of 12609286 and a Short% of Float of 11.07.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 2.0 analysts are dedicated to thoroughly evaluating and rating the performance of Vaxcyte Inc (PCVX) in the stock market.The consensus estimate for the next quarter is -$0.97, with high estimates of -$0.86 and low estimates of -$1.08.
Analysts are recommending an EPS of between -$3.48 and -$4.88 for the fiscal current year, implying an average EPS of -$4.3. EPS for the following year is -$4.72, with 5.0 analysts recommending between -$4.14 and -$5.42.
